U.S. Bioscience regulatory update

The FDA's Oncologic Drugs Advisory Committee will review on June 8 UBS's supplemental NDA (sNDA) for Ethyol amifostine to reduce the incidence and severity of radiation-induced xerostomia (dry mouth)...